Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

SGMOQ holding history

Sangamo Therapeutics, Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SGMOQ overviewAll 13F holders of SGMOQFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SGMOQ by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−400,000−100.0%Sold outHolders
Q3 2025400,000$269.0K<0.1%00.0%UnchangedHolders
Q2 2025400,000$217.0K<0.1%00.0%UnchangedHolders
Q1 2025400,000$262.0K<0.1%00.0%UnchangedHolders
Q4 2024400,000$408.0K<0.1%00.0%UnchangedHolders
Q3 2024400,000$346.0K<0.1%−7,669−1.9%ReducedHolders
Q2 2024407,669$145.7K<0.1%+7,669+1.9%AddedHolders
Q1 2024400,000$268.0K<0.1%00.0%UnchangedHolders
Q4 2023400,000$217.0K<0.1%00.0%UnchangedHolders
Q3 2023400,000$240.0K<0.1%00.0%UnchangedHolders
Q2 2023400,000$520.0K<0.1%00.0%UnchangedHolders
Q1 2023400,000$704.0K<0.1%00.0%UnchangedHolders
Q4 2022400,000$1.26M<0.1%−260−0.1%ReducedHolders
Q3 2022400,260$1.97M<0.1%−1,875−0.5%ReducedHolders
Q2 2022402,135$1.67M<0.1%00.0%UnchangedHolders
Q1 2022402,135$2.34M<0.1%00.0%UnchangedHolders
Q4 2021402,135$3.02M<0.1%00.0%UnchangedHolders
Q3 2021402,135$3.62M<0.1%00.0%UnchangedHolders
Q2 2021402,135$4.81M<0.1%−976−0.2%ReducedHolders
Q1 2021403,111$5.05M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.